Owkin Raises $180M in Series C

Owkin has successfully raised $180M in a Series C at a $1B valuation led by Sanofi Ventures, GV.

Company Overview

Owkin is a HealthTech company headquartered in New York, NY, founded in 2016 with 200+ employees.

AI for drug discovery and diagnostics

Fundraising Details

- Amount Raised: $180M
- Round Type: Series C
- Valuation: $1B
- Date: 2021-06-22
- Investors: Sanofi Ventures, GV

About Owkin

AI for drug discovery and diagnostics The company is positioned in the HealthTech sector, serving a growing market with innovative solutions.

Key Information

- Headquarters: New York, NY
- Founded: 2016
- Team Size: 200+
- Industry: HealthTech

What This Means

This funding round demonstrates strong investor confidence in Owkin's vision and execution. The capital will likely be used to:

- Scale Operations: Expand the team and operational capacity
- Product Development: Enhance existing products and develop new features
- Market Expansion: Enter new markets and strengthen presence in existing ones
- Technology Investment: Invest in infrastructure and technology capabilities

Industry Context

The HealthTech sector continues to attract significant investment as companies innovate to meet evolving market demands. Owkin's successful fundraising reflects the strong fundamentals and growth potential in this space.

Valuation Milestone

Reaching a $1B valuation marks an important milestone for Owkin, positioning the company among notable players in the HealthTech industry.

Looking Ahead

With this new capital, Owkin is well-positioned to execute on its growth strategy and continue building innovative solutions in the HealthTech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.

---

This fundraising news was reported on 2021-06-22. For more information about Owkin, visit their headquarters at New York, NY.